Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules
  • Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules
  • Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules
  • Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules
  • Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules
  • Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules
Find Similar Products

Basic Info.

Model NO.
AMC14010-01
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Oral Liquid
Type
Biological Products
Pharmaceutical Technology
Chemical Synthesis
Deliver Time
30-40days
Transport Package
10′s/Box
Specification
4mg/1ml
Trademark
Shinepharm
Origin
China
HS Code
3004909099
Production Capacity
100000boxes/Month

Product Description

Dexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules

Indications:
Dexamethason Solution for Injection is indicated in acute conditions in which oral glucocorticoid therapy is not feasible such as:

Shock: of haemorrhagic, traumatic, surgical or septic origin; cerebral oedema associated with cerebral neoplasm; inflammatory diseases of joints and soft tissue such as rheumatoid arthritis.

Short term management of acute self-limited allergic conditions such as angioneurotic oedema or acute exacerbations of chronic allergic disorders such as bronchial asthma or serum sickness.

Dosage and Administration:

Dexamethason sodium phosphate injection may be administered by intramuscular, intraarticular or direct intravenous injection, intravenous infusion or soft tissue infiltration.

Intravenous and Intramuscular Administration: IM or IV dosage of dexamethason is variable, depending on the condition being treated. It usually ranges from 0.4 to 20 mg (0.1 to 6 ml) daily. The duration of therapy is dependent on the clinical response of the patient and as soon as improvement is indicated, the dosage should be adjusted to the minimum required to maintain the desired clinical response. Withdrawal of the drug on completion of therapy should be gradual.

Precautions & Warning:

Dexamethason withdrawal

Visual disturbance

Hypertrophic cardiomyopathy(In paediatric population)

Contra-indications:

Unless considered to be life-saving systemic administration of corticosteroids are generally contraindicated in patients with systemic infections, (unless specific anti-infective therapy is employed).

Hypersensitivity to any components of the injection.

Drug interactions:

Liver enzyme inducing drugs

Coumarin anticoagulants

Anti-inflammatory drugs

Salicylate

Diuretics

Co-treatment with CYP3A inhibitors

Storage instructions:

Do not store above 25°C. Do not freeze. Keep container in the outer carton.

Dexamethason Sodium Phosphate Injection 4mg/1ml 10 AmpoulesDexamethason Sodium Phosphate Injection 4mg/1ml 10 AmpoulesDexamethason Sodium Phosphate Injection 4mg/1ml 10 AmpoulesDexamethason Sodium Phosphate Injection 4mg/1ml 10 AmpoulesDexamethason Sodium Phosphate Injection 4mg/1ml 10 AmpoulesDexamethason Sodium Phosphate Injection 4mg/1ml 10 Ampoules

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier